|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/09/24 Angiodynamics Inc. 10-Q 2/29/24 86:7.1M Workiva Inc Wde… FA01/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.32M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 27K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 24K
11: R1 Cover Page HTML 81K
12: R2 Consolidated Statements of Operations HTML 117K
13: R3 Consolidated Statements of Comprehensive Loss HTML 53K
14: R4 Consolidated Balance Sheets HTML 136K
15: R5 Consolidated Balance Sheets (Parenthetical) HTML 48K
16: R6 Consolidated Statements of Cash Flows HTML 119K
17: R7 Consolidated Statements of Stockholders' Equity HTML 133K
18: R8 Consolidated Financial Statements HTML 27K
19: R9 Divestitures HTML 42K
20: R10 Revenue from Contracts with Customers HTML 78K
21: R11 Inventories HTML 32K
22: R12 Goodwill and Intangible Assets HTML 77K
23: R13 Accrued Liabilities HTML 38K
24: R14 Long-Term Debt HTML 25K
25: R15 Income Taxes HTML 30K
26: R16 Share-Based Compensation HTML 31K
27: R17 Earnings Per Share HTML 37K
28: R18 Segment and Geographic Information HTML 67K
29: R19 Fair Value HTML 72K
30: R20 Leases HTML 65K
31: R21 Commitments and Contingencies HTML 29K
32: R22 Acquisition, Restructuring and Other Items, Net HTML 112K
33: R23 Accumulated Other Comprehensive Income HTML 35K
34: R24 Recently Issued Accounting Pronouncements HTML 44K
35: R25 Subsequent Events HTML 27K
36: R26 Pay vs Performance Disclosure HTML 36K
37: R27 Insider Trading Arrangements HTML 29K
38: R28 Recently Issued Accounting Pronouncements HTML 48K
(Policies)
39: R29 Divestitures (Tables) HTML 41K
40: R30 Revenue from Contracts with Customers (Tables) HTML 64K
41: R31 Inventories (Tables) HTML 32K
42: R32 Goodwill and Intangible Assets (Tables) HTML 79K
43: R33 Accrued Liabilities (Tables) HTML 38K
44: R34 Earnings Per Share (Tables) HTML 36K
45: R35 Segment and Geographic Information (Tables) HTML 63K
46: R36 Fair Value (Tables) HTML 72K
47: R37 Leases (Tables) HTML 67K
48: R38 Acquisition, Restructuring and Other Items, Net HTML 109K
(Tables)
49: R39 Accumulated Other Comprehensive Loss (Tables) HTML 34K
50: R40 Divestitures - Narrative (Details) HTML 40K
51: R41 Divestitures - Summary of Major Classes of Assets HTML 60K
Sold (Details)
52: R42 Revenue from Contracts with Customers - HTML 45K
Disaggregation of Revenue (Details)
53: R43 Revenue from Contracts with Customers - Narrative HTML 40K
(Details)
54: R44 Revenue from Contracts with Customers - Contract HTML 30K
Balances with Customers (Details)
55: R45 Inventories - Schedule of Inventories (Details) HTML 31K
56: R46 Inventories - Narrative (Details) HTML 25K
57: R47 Goodwill and Intangible Assets - Narrative HTML 46K
(Details)
58: R48 Goodwill and Intangible Assets - Change in HTML 42K
Goodwill (Details)
59: R49 Goodwill and Intangible Assets - Intangible Assets HTML 42K
(Details)
60: R50 Goodwill and Intangible Assets - Expected Future HTML 38K
Amortization Expense (Details)
61: R51 Accrued Liabilities (Details) HTML 45K
62: R52 Income Taxes (Details) HTML 25K
63: R53 Share-Based Compensation (Details) HTML 49K
64: R54 Earnings Per Share (Details) HTML 33K
65: R55 Segment and Geographic Information - Narrative HTML 47K
(Details)
66: R56 Segment and Geographic Information - Summary of HTML 44K
Net Sales by Product Category (Details)
67: R57 Segment and Geographic Information - Summary of HTML 33K
Net Sales by Geographic Area (Details)
68: R58 Fair Value - Fair Value of Assets and Liabilities HTML 36K
Measured on a Recurring Basis (Details)
69: R59 Fair Value - Fair Value Measurements Using HTML 33K
Significant Unobservable Inputs (Details)
70: R60 Fair Value - Summary Showing the Recurring Fair HTML 44K
Value Measurements of the Contingent Consideration
Liability (Details)
71: R61 Fair Value - Additional Information (Details) HTML 25K
72: R62 Leases - Supplemental Balance Sheet Information HTML 42K
(Details)
73: R63 Leases - Liability Maturity Schedule (Details) HTML 44K
74: R64 Leases - Supplemental Statement of Operations HTML 35K
Information (Details)
75: R65 Leases - Supplemental Cash Flow Information HTML 28K
(Details)
76: R66 Commitments and Contingencies (Details) HTML 43K
77: R67 Acquisition, Restructuring and Other Items, Net - HTML 64K
Schedule of Acquisition, Restructuring and Other
Items, Net (Details)
78: R68 Acquisition, Restructuring and Other Items, Net - HTML 63K
Summary of Estimated Costs (Details)
79: R69 Acquisition, Restructuring and Other Items, Net - HTML 54K
Restructuring Reserve (Details)
80: R70 Accumulated Other Comprehensive Loss (Details) HTML 39K
81: R71 Subsequent Events (Details) HTML 51K
83: XML IDEA XML File -- Filing Summary XML 155K
86: XML XBRL Instance -- ango-20240229_htm XML 1.77M
82: EXCEL IDEA Workbook of Financial Report Info XLSX 141K
7: EX-101.CAL XBRL Calculations -- ango-20240229_cal XML 197K
8: EX-101.DEF XBRL Definitions -- ango-20240229_def XML 504K
9: EX-101.LAB XBRL Labels -- ango-20240229_lab XML 1.45M
10: EX-101.PRE XBRL Presentations -- ango-20240229_pre XML 958K
6: EX-101.SCH XBRL Schema -- ango-20240229 XSD 147K
84: JSON XBRL Instance as JSON Data -- MetaLinks 478± 691K
85: ZIP XBRL Zipped Folder -- 0001628280-24-015487-xbrl Zip 313K
| Document |
| 1. | I have reviewed this quarterly report on Form 10-Q of AngioDynamics, Inc.; | |||||||
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | |||||||
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | |||||||
| 4. | The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: | |||||||
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |||||||
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |||||||
| (c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |||||||
| (d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and | |||||||
| 5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): | |||||||
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and | |||||||
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. | |||||||
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/9/24 | |||
| For Period end: | 2/29/24 | 4 | ||
| List all Filings | ||||